Altered methionine metabolism in metastatic variants of a human melanoma cell line

Cancer Lett. 1989 Jan;44(1):23-31. doi: 10.1016/0304-3835(89)90103-1.

Abstract

In order to identify the biochemical defect(s) responsible for the reduced levels of DNA 5-methylcytosine (5-mCyt) found within highly metastatic (in athymic "nude" mice) variants of the poorly metastatic human melanoma cell line MeWo, the ability of these cells to grow in culture medium devoid of exogenous methionine but containing either homocysteine (Hcy) or 5'-deoxy-5'-methylthioadenosine (MeSAdo) was determined. In contrast to the parental MeWo tumor line, many (but not all) of these malignant variants were completely unable to proliferate in methionine-free homocysteine-containing medium. Many of these malignant variants also exhibited a reduced ability to proliferate in methionine-free MeSAdo-containing medium. Cell lines established from "artificial" metastases of MeWo or its cloned sublines, exhibited no consistent reduction in their ability to grow in methionine-free medium containing either Hcy or MeSAdo. These observations suggest that alterations in S-adenosylmethionine(AdoMet)-dependent transmethylation reactions may contribute to "progression" of the MeWo tumor from a relatively benign to a highly autonomous and malignant state.

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • Cell Division
  • Culture Media
  • Homocysteine / pharmacology
  • Humans
  • Melanoma / metabolism*
  • Melanoma / pathology
  • Methionine / metabolism*
  • Neoplasm Metastasis*
  • S-Adenosylmethionine / metabolism
  • Tumor Cells, Cultured
  • Vitamin B 12 / pharmacology

Substances

  • Culture Media
  • Homocysteine
  • S-Adenosylmethionine
  • Methionine
  • Vitamin B 12